Literature DB >> 32954746

Negative results in nucleic acid test of COVID-19 patients: assessment from the perspective of clinical laboratories.

Wenjia Guo1, Qi Zhou2, Jiancheng Xu3.   

Abstract

Since December 2019, there had been an outbreak of coronavirus disease 2019 (COVID-19). Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is prevalent around the world, and the number of infected cases has increased rapidly. Viral nucleic acid test of SARS-CoV-2 can provide direct evidence for rapid diagnosis, disease course monitoring, and therapeutic efficacy. However, in practice, false-negative results in nucleic acid test are common, causing missed diagnoses, which are not conducive to the prevention and control of this outbreak. This article analyzes the possible causes and proposed measures to reduce the false-negative rate of nucleic acid test results and more effectively curb the outbreak.

Entities:  

Keywords:  Coronavirus disease 2019 (COVID-19); nucleic acid test; real-time fluorescence polymerase chain reaction (RT-PCR)

Mesh:

Year:  2020        PMID: 32954746     DOI: 10.21037/apm-20-568

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  5 in total

1.  Epidemiological Characteristics of COVID-19 Resurgence in Areas Initially Under Control.

Authors:  Yazhen Li; Kai Yang; Shanshan Zha; Lingwei Wang; Rongchang Chen
Journal:  Front Public Health       Date:  2021-11-23

2.  The utility of SARS-CoV-2-specific serology in COVID-19 diagnosis.

Authors:  Tasnim Hasan; H Ling Lim; Jennifer Case; Linda Hueston; Shopna Bag; Dominic E Dwyer; Matthew V N O'Sullivan
Journal:  Aust N Z J Public Health       Date:  2021-11-11       Impact factor: 2.939

3.  Estimate false-negative RT-PCR rates for SARS-CoV-2. A systematic review and meta-analysis.

Authors:  Valentina Pecoraro; Antonella Negro; Tommaso Pirotti; Tommaso Trenti
Journal:  Eur J Clin Invest       Date:  2021-12-05       Impact factor: 5.722

4.  Comparison of Four Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2 in Respiratory Samples from Tunja, Boyacá, Colombia.

Authors:  Lorenzo H Salamanca-Neita; Óscar Carvajal; Juan Pablo Carvajal; Maribel Forero-Castro; Nidya Alexandra Segura
Journal:  Trop Med Infect Dis       Date:  2022-09-10

5.  Guidelines on newly identified limitations of diagnostic tools for COVID-19 and consequences.

Authors:  Kirtimaan Syal
Journal:  J Med Virol       Date:  2020-12-17       Impact factor: 20.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.